Metformin for Weight Loss in Schizophrenia
The Carlat Psychiatry Report, Volume 11, Number 11, November 2013
Obesity and metabolic impairments are widespread in both psychiatric and non-psychiatric populations. To make matters worse, weight gain, hyperlipidemia, and diabetes are common side effects of the pharmaceuticals we use to treat psychiatric illness.
Section editor, Glen Spielmans, PhD
Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.